Category: MedtronicSyndicate content

Medtronic taps Brigham & Women's prez Nabel for board | Personnel Moves

September 18, 2014 by Brad Perriello

Medtronic taps Dr. Elizabeth Nabel, president of Brigham & Women's Faulkner Hospital in Boston, for a seat on its board of directors.

Medtronic taps Brigham & Women's prez Nabel for board | Personnel Moves

Medtronic and Covidien prepare 1st Integration Summit

September 18, 2014 by Arezu Sarvestani

Merging medtech titans Medtronic and Covidien are preparing to host the 1st of 4 Integration Summits, scheduled later this month.

Medtronic and Covidien prepare 1st Integration Summit

Inside the Medtronic-Covidien deal: Contrasting styles brought the companies together

September 17, 2014 by Brian Johnson

A senior executive at Medtronic, vice president of corporate development Chris Cleary, explains how Covidien played "scrappy" upstart all the way to a $43 billion payout.

Inside the Medtronic-Covidien deal: Contrasting styles brought the companies together

Medtronic unveils next-gen balloon kyphoplasty

September 17, 2014 by Arezu Sarvestani

Minnesota medtech giant Medtronic launches its Kyphon Express II balloon kyphoplasty system for treating vertebral compression fractures.

Medtronic unveils next-gen ballook kyphoplasty

Medtronic (NYSE:MDT) officially launched the latest in its line of balloon kyphoplasty (BKP) technologies, the Kyphon Express II, for use in treating vertebral compression fractures.

TCT 2014: Another trial shows no benefit for renal denervation in hypertension

September 17, 2014 by Brad Perriello

Another trial of Medtronic's Symplicity renal denervation device in treating hypertension shows no benefit compared with a sham procedure.

TCT 2014: Another Medtronic trial shows no benefit for renal denervation in hypertension

Integra LifeSciences to pay $60M for Medtronic ENT instruments

September 17, 2014 by Brad Perriello

Integra LifeSciences agrees to pay $60 million to acquire a pair of Medtronic's ear, nose & throat instrument lines.

Integra LifeSciences to pay $60M for Medtronic ENT instruments

Diabetes: Medtronic study finds pumps beat injections for patient satisfaction

September 17, 2014 by Arezu Sarvestani

New results from Medtronic's OpT2mise clinical trial find that Type 2 diabetics with insulin pumps are happier with their therapy than those relying on multiple daily injections.

Diabetes: Medtronic study finds pumps beat injections for patient satisfaction

Insulin pumps beat manual injections for managing symptoms of Type 2 diabetes, according to the latest results from Medtronic's (NYSE:MDT) OpT2mise clinical trials.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp